F. Le Frère

An intermediate level of CD161 expression defines a novel activated, inflammatory, and pathogenic subset of CD8+ T cells involved in multiple sclerosis.

P. Gourraud, Stéphanie Kilens, S. Nedellec, 2017, Journal of autoimmunity.

Patients With Severe Multiple Sclerosis Exhibit Functionally Altered CD8+ Regulatory T Cells

L. Flippe, S. Remy, I. Anegon, 2022, Neurology: Neuroimmunology & Neuroinflammation.

Neuropathologic, phenotypic and functional analyses of Mucosal Associated Invariant T cells in Multiple Sclerosis.

S. Nedellec, D. Laplaud, S. Brouard, 2016, Clinical immunology.

Increased risk of multiple sclerosis relapse after in vitro fertilisation

M. Clanet, S. Vukusic, B. Brochet, 2012, Journal of Neurology Neurosurgery & Psychiatry.

SMILE: a predictive model for Scoring the severity of relapses in MultIple scLErosis

B. Brochet, G. Edan, D. Laplaud, 2020, Journal of Neurology.

Immune Profiling Reveals the T-Cell Effect of Ocrelizumab in Early Relapsing-Remitting Multiple Sclerosis

S. Vukusic, E. Thouvenot, P. Gourraud, 2023, Neurology: Neuroimmunology & Neuroinflammation.